Abstract:Alternative splicing plays a crucial role in protein diversity and gene expression regulation in higher eukaryotes, and mutations causing dysregulated splicing underlie a range of genetic diseases. Computational prediction of alternative splicing from genomic sequences not only provides insight into gene-regulatory mechanisms but also helps identify disease-causing mutations and drug targets. However, the current methods for the quantitative prediction of splice site usage still have limited accuracy. Here, we present DeltaSplice, a deep neural network model optimized to learn the impact of mutations on quantitative changes in alternative splicing from the comparative analysis of homologous genes. The model architecture enables DeltaSplice to perform "reference-informed prediction" by incorporating the known splice site usage of a reference gene sequence to improve its prediction on splicing-altering mutations. We benchmarked DeltaSplice and several other state-of-the-art methods on various prediction tasks, including evolutionary sequence divergence on lineage-specific splicing and splicing-altering mutations in human populations and neurodevelopmental disorders, and demonstrated that DeltaSplice outperformed consistently. DeltaSplice predicted ~15% of splicing quantitative trait loci (sQTLs) in the human brain as causal splicing-altering variants. It also predicted splicing-altering de novo mutations outside the splice sites in a subset of patients affected by autism and other neurodevelopmental disorders (NDDs), including 19 genes with recurrent splicing-altering mutations. Integration of splicing-altering mutations with other types of de novo mutation burdens allowed the prediction of eight novel NDD-risk genes. Our work expanded the capacity of in silico splicing models with potential applications in genetic diagnosis and the development of splicing-based precision medicine.

Deep indel mutagenesis reveals the regulatory and modulatory architecture of alternative exon splicing

One-Size-Fits-Many: Antisense oligonucleotides for rescuing splicing mutations in hotspot exons

Coordinated alternative splicing decisions via stepwise exon definition

From computational models of the splicing code to regulatory mechanisms and therapeutic implications

Mutually Exclusive Alternative Splicing of Pre‐mrnas

Systematically developing a registry of splice-site creating variants utilizing massive publicly available transcriptome sequence data

Reference-informed prediction of alternative splicing and splicing-altering mutations from sequences

The human splicing code reveals new insights into the genetic determinants of disease

Alternative Splicing As a Biomarker and Potential Target for Drug Discovery

Antisense oligonucleotide modulation of non-productive alternative splicing upregulates gene expression

Genomic features defining exonic variants that modulate splicing

Disentangling the splicing factor programs underlying complex molecular phenotypes

Splicing activates transcription from weak promoters upstream of alternative exons

Transcriptome-wide splicing network reveals specialized regulatory functions of the core spliceosome

Genomics of alternative splicing: evolution, development and pathophysiology

Mechanisms of Alternative Splicing Regulation: Insights from Molecular and Genomics Approaches

Genetic regulation of nascent RNA maturation revealed by direct RNA nanopore sequencing

Prioritizing Single-Nucleotide Variations That Potentially Regulate Alternative Splicing.

ExonImpact: Prioritizing Pathogenic Alternative Splicing Events.

CRISPR-dCas13d-based deep screening of proximal and distal splicing-regulatory elements